Revenue: The sum of all revenue fields included for a company's operating activities.
Aspire Biopharma Holdings, Inc. (ASBP) had Revenue of $0.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$0.00M |
$-4.71M |
|
$0.01M |
|
$-0.00M |
|
$1.85M |
|
$-1.85M |
|
$-2.86M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-1.85M |
|
$4.15M |
|
1.50M |
|
1.50M |
|
$3.62 |
|
$3.62 |
|
| Balance Sheet Financials | |
$1.31M |
|
-- |
|
-- |
|
$1.31M |
|
$7.59M |
|
-- |
|
$0.10M |
|
$7.69M |
|
$-6.38M |
|
$-6.38M |
|
$-6.38M |
|
3.53M |
|
| Cash Flow Statement Financials | |
$-4.92M |
|
-- |
|
$5.92M |
|
$0.00M |
|
$1.00M |
|
$1.00M |
|
$14.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.17 |
|
-- |
|
-- |
|
-- |
|
-0.81 |
|
-23.47% |
|
-43403.48% |
|
-43403.48% |
|
-- |
|
-110484.30% |
|
-110484.30% |
|
$-4.92M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
-- |
|
-- |
|
73.83% |
|
73.83% |
|
-358.78% |
|
73.83% |
|
$-1.80 |
|
$-3.29 |
|
$-3.29 |
|